Insulin Independence in Newly Diagnosed Type 1 Diabetes Patient following Fenofibrate Treatment
A 19-year-old girl was diagnosed with type 1 diabetes and showing polydipsia and polyuria. She was double autoantibody-positive and had a diabetes-prone tissue type. She was immediately started on insulin. Fenofibrate treatment (160 mg daily) was initiated seven days after diagnosis. The need for in...
Saved in:
Main Authors: | Karsten Buschard, Laurits J. Holm, Ulla Feldt-Rasmussen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/6865190 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Initial Assessment of Daily Insulin Dose in Chinese Newly Diagnosed Type 2 Diabetes
by: Jing Ma, et al.
Published: (2016-01-01) -
A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes
by: Shuo Lin, et al.
Published: (2018-01-01) -
The Relationship between Serum 25-Hydroxy Vitamin D and Insulin Sensitivity and β-Cell Function in Newly Diagnosed Type 2 Diabetes
by: Yuan Gao, et al.
Published: (2015-01-01) -
Renal Dysfunction and Recovery following Initial Treatment of Newly Diagnosed Multiple Myeloma
by: Benjamin A. Derman, et al.
Published: (2018-01-01) -
Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research)
by: Guang Yang, et al.
Published: (2016-01-01)